Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 59, Issue 21, Pages 9866-9880Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01194
Keywords
-
Categories
Funding
- National Institute of Mental Health (NIMH) [R01MH99993]
- Psychoactive Drug Screening Program (PDSP) [HHSN-271-2013-00017-C]
Ask authors/readers for more resources
On the basis of the structural similarity of our previous 5-HT2c agonists with the melatonin receptor agonist tasimelteon and the putative biological cross-talk between serotonergic and melatonergic systems, a series of new (2,3-dihydro)benzofuran-based compounds were designed and synthesized. The compounds were evaluated for their selectivity toward 5-HT2A, 5-HT2B, and 5HT(2c) receptors in the calcium flux assay with the ultimate goal to generate selective 5-HT2c agonists. Selected compounds were studied for their functional selectivity by comparing their transduction efficiency at the G protein signaling pathway versus beta-arrestin recruitment. The most functionally selective compound (+)-7e produced weak beta-arrestin recruitment and also demonstrated less receptor desensitization compared to serotonin in both calcium flux and phosphoinositide (PI) hydrolysis assays. We report for the first time that selective 5-HT2c agonists possessing weak beta-arrestin recruitment can produce distinct receptor desensitization properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available